Drug developers and global regulators are rapidly expanding the use of real-world evidence (RWE) to design, test, and review rare disease treatments, but knowledge gaps on the part of payers […]
To the uninitiated, the term “advanced analytics” might sound a bit dry, but it holds exciting promise to make clinical trials far more efficient and deliver vital drugs and treatments […]
A new guidance from the U.S. Food and Drug Administration (FDA) offers the agency’s latest thinking on how industry should design, run, and handle data reporting when leveraging adaptive clinical […]
Maybe it’s all that sunshine, but the value of certification in improving clinical trial workforce quality standards is clear to see in Florida, where the University of Florida’s (UF’s) Clinical […]
Organizational barriers and silos—both real and imagined—hamper clinical trial performance in a number of ways. While some obstacles are probably inevitable given the complexity and breadth of conducting a trial, […]